Autoantibodies || p53 AUTOANTIBODIESHERKEL, JOHANNES · 2007

Serum p53 autoantibodies: incidence in ovarian carcinomaK.A. Angelopoulou; M. Stratis; E.P. Diamandis · 1995

p53 autoantibodies in patients with urological tumoursLang; Unteregger; Kartarius; GÜnther; Bonkhoff; Montenarh; Zwergel · 1998

P53 autoantibodies in lung cancer: A serum analysisDaniel, C.M.; Robinet, G.; Metges, J.; Gouva, S. · Lung Cancer · 2000

P53 autoantibodies in 1006 patients followed up for breast cancerSu Metcalfe, TerenceK Wheeler, Sheila Picken, Susanne Negus… · 2000

p53 autoantibodies predict subsequent development of cancerYongliang Li; Antti Karjalainen; Heikki Koskinen; Kari Hemminki; Harri Vainio; Michael Shnaidman; Zhiliang Ying; Eero Pukkala; Paul W. Brandt-Rauf · 2005

p53 autoantibodies, cytokine levels and ovarian carcinogenesisMiyun Tsai-Turton; Antonio Santillan; Dan Lu; Robert E. Bristow; Kwun C. Chan; Ie-Ming Shih; Richard B.S. Roden · 2009

The immunobiology of primary sclerosing cholangitisChristopher A. Aoki; Christopher L. Bowlus; M. Eric Gershwin · 2005

T cell immunity in autoimmune hepatitisYasunori Ichiki; Christopher A. Aoki; Christopher L. Bowlus; Shinji Shimoda; Hiromi Ishibashi; M. Eric Gershwin · 2005

Revisiting Hereditary Hemochromatosis: Current Concepts and ProgressAndrew W. Yen; Tonya L. Fancher; Christopher L. Bowlus · 2006

The immunobiology of primary sclerosing cholangitisJonathan H. Aron; Christopher L. Bowlus · 2009

The geoepidemiology of autoimmune intestinal diseasesIan Logan; Christopher L. Bowlus · 2010

Primary Sclerosing CholangitisSarkar, Souvik; Bowlus, Christopher L. · Clinics in Liver Disease · 2016

IL-2 receptor alpha deficiency and features of primary biliary cirrhosisChristopher A. Aoki; Chaim M. Roifman; Zhe-Xiong Lian; Christopher L. Bowlus; Gary L. Norman; Yehuda Shoenfeld; Ian R. Mackay; M. Eric Gershwin · 2006